Emmanuelle Charpentier

Nobel Prize Winner
CRISPR-Cas9 Pioneer
Molecular Biologist
50K Followers
5M Net Worth
Max Planck Institute, University of California, Berkeley Brands

Brands Emmanuelle Charpentier talks about

ERS Genomics
Emmanuelle Charpentier
8 months ago 3 views
A
Answer ERS Genomics
Emmanuelle Charpentier co-founded ERS Genomics to develop and license the core intellectual property of the CRISPR-Cas9 technology for various biotechnology and biomedical applications.

Similar people